Bennet and Lorraine review their direct experiences with Dexcom CGM spanning the past seven years from Dexcom Seven Plus to the current Dexcom G5. They discuss the near revolutionary impacts the improvements in CGM technology have had on their children’s type 1 diabetes care.
They discuss changes in overnight care, its usefulness for people living with type 2 diabetes, and what they see CGM’s role will be in the future.
In addition, they share highlights of the recent earnings calls for Dexcom and Insulet including what’s in store for the near future for both Dexcom and Omnipod. Listen in for all the news!
Please visit us at www.diabetesoutloud.org for more information and leave us SpeakPipe message! We want to hear from you!